32
Participants
Start Date
May 16, 2016
Primary Completion Date
June 15, 2016
Study Completion Date
June 21, 2016
Omeprazole
20 mg oral capsules administered once daily for 10 days
Omeprazole
40 mg oral capsules administered twice daily for 10 days
Gefapixant
Gefapixant oral tablets (15 mg administered as two 7.5 mg tablets) administered twice daily for 15 days
Gefapixant
Gefapixant oral tablets (30 mg administered as four 7.5 mg tablets) administered twice daily for 15 days
Celerion, Tempe
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
INDUSTRY